How to de-risk your clinical development plan

Webinar How to de-risk your clinical development plan This webinar is designed to provide you with essential strategies and insights to navigate and mitigate risks in your clinical development processes. In this webinar, Dr Karen Mullen, Chief Medical Officer, and Dr Harriet Gray Stephens, Medical Director at Boyds, discuss how to de-risk your clinical development […]

How to de-risk your IND: Strategy & planning and operational considerations

Webinar How to De-Risk your IND This webinar is designed to provide a plan of action that can help to de-risk your Investigational New Drug (IND) application and expedite the path to gaining study clearance. Dr. Nick Meyers, Vice President of Product Development and Katy Rudnick, Head of US Regulatory Affairs, will take you through […]

Early stage development: Challenges and solutions

Webinar Early-Stage Drug Development: Challenges and Solutions This free webinar focuses on some of the most common challenges faced by biotechs, academic groups and pharma companies in the very early phases of developing drugs, whether they be small molecules, traditional biologics or advanced therapies. Dr Nick Meyers, Vice President of Product Development at Boyds, shares his insights […]